Skip to content

Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion

Comparaison d'un Traitement systématique à l'héparine Versus sélectif Pour la prévention de l'Occlusion Radiale EASY-Héparine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06981624
Acronym
EASY-Heparin
Enrollment
500
Registered
2025-05-21
Start date
2025-05-13
Completion date
2026-12-01
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radial Artery Occlusion

Brief summary

Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-artery compression system.

Interventions

Hemostasis achieved using a dual-artery compression device without administration of heparin after trans-radial diagnostic catheterization

Sponsors

Olivier F. Bertrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any patient referred for a diagnostic transradial catheterism

Exclusion criteria

* Unable to understand study design or provide informed consent * Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine * Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access. * Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.

Design outcomes

Primary

MeasureTime frameDescription
Rates of patent hemostasiswithin 24 hours after diagnostic angiographyEvaluation of patent hemostasis by pulse oximetry
Time to hemostasiswithin 24 hours post-procedure
Nursing time involvementwithin 24 hours post-procedureCalculation of nursing time required for surveillance and care of hemostasis
Evaluation of complicationswithin 30 days of procedureCompilation of access site complications such as radial artery occlusion, bleeding, presence and grading of hematomas, etc.

Countries

Canada

Contacts

CONTACTMichele Jadin
michele.jadin@criucpq.ulaval.ca418-656-8711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026